
Galera Schedules Type A Meeting with FDA to Discuss Next Steps for Avasopasem
MALVERN, PA — Galera Therapeutics, Inc. (Nasdaq: GRTX) recently announced that a Type A Meeting has been scheduled for September 28, 2023, with the U.S. Food and Drug Administration (FDA) …
Galera Schedules Type A Meeting with FDA to Discuss Next Steps for Avasopasem Read More